The store will not work correctly when cookies are disabled.
1-(3-Methylbenzoyl)-5-nitro-1H-indazole-3-carboxylic Acid methyl ester
ID: ALA2409452
PubChem CID: 71818689
Max Phase: Preclinical
Molecular Formula: C17H13N3O5
Molecular Weight: 339.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1nn(C(=O)c2cccc(C)c2)c2ccc([N+](=O)[O-])cc12
Standard InChI: InChI=1S/C17H13N3O5/c1-10-4-3-5-11(8-10)16(21)19-14-7-6-12(20(23)24)9-13(14)15(18-19)17(22)25-2/h3-9H,1-2H3
Standard InChI Key: WQDQVYGCTAVNKI-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.6925 -10.1323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6913 -10.9518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3994 -11.3608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3976 -9.7234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1062 -10.1287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1064 -10.9519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8877 -11.2088 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3731 -10.5399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8887 -9.8747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8741 -12.0244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1590 -12.4200 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5742 -12.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5570 -13.2616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2563 -13.6829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9724 -13.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9847 -12.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2848 -12.0483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2630 -9.1483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0792 -9.1092 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5212 -9.7966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8210 -8.4609 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6984 -12.0678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9839 -9.7241 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2763 -10.1329 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9838 -8.9069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
18 19 1 0
19 20 1 0
18 21 2 0
16 22 1 0
23 24 2 0
23 25 1 0
1 23 1 0
M CHG 2 23 1 25 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 339.31 | Molecular Weight (Monoisotopic): 339.0855 | AlogP: 2.73 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.33 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.11 | CX LogD: 3.11 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.41 | Np Likeness Score: -1.56 |
References
1. Crocetti L, Schepetkin IA, Cilibrizzi A, Graziano A, Vergelli C, Giomi D, Khlebnikov AI, Quinn MT, Giovannoni MP.. (2013) Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase., 56 (15): [PMID:23844670] [10.1021/jm400742j] |